Rana Mckay

Title(s)Associate Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Correction: Germline alterations among Hispanic men with prostate cancer. Prostate Cancer Prostatic Dis. 2022 Sep; 25(3):599. Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. PMID: 35488122.
      View in: PubMed   Mentions:    Fields:    
    2. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma. Eur Urol. 2022 Jul 14. Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S. PMID: 35843777.
      View in: PubMed   Mentions:    Fields:    
    3. The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. Clin Genitourin Cancer. 2022 Jun 30. Lee AM, Saidian A, Shaya J, Nonato T, Cabal A, Randall JM, Millard F, Stewart T, Rose B, Tamayo P, McKay RR. PMID: 35871039.
      View in: PubMed   Mentions:    Fields:    
    4. Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. Eur J Cancer. 2022 08; 171:124-132. Graham J, Wells JC, Dudani S, Gan CL, Donskov F, Lee JL, Kollmannsberger CK, Meza L, Beuselinck B, Hansen A, North SA, Bjarnason GA, Sayegh N, Kanesvaran R, Wood LA, Hotte SJ, McKay RR, Choueiri TK, Heng DYC. PMID: 35717820.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021). Lancet Oncol. 2022 07; 23(7):899-909. Agarwal N, McGregor B, Maughan BL, Dorff TB, Kelly W, Fang B, McKay RR, Singh P, Pagliaro L, Dreicer R, Srinivas S, Loriot Y, Vaishampayan U, Goel S, Curran D, Panneerselvam A, Schwickart M, Choueiri TK, Pal S. PMID: 35690072.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2022 Jun 05. Makrakis D, Talukder R, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Jang A, Barata P, Sonpavde G, Yu EY, Montgomery RB, Grivas P, Khaki AR. PMID: 35778337.
      View in: PubMed   Mentions:    Fields:    
    7. Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma. JAMA Netw Open. 2022 06 01; 5(6):e2216379. Navani V, Ernst M, Wells JC, Yuasa T, Takemura K, Donskov F, Basappa NS, Schmidt A, Pal SK, Meza L, Wood LA, Ernst DS, Szabados B, Powles T, McKay RR, Weickhardt A, Suarez C, Kapoor A, Lee JL, Choueiri TK, Heng DYC. PMID: 35687336; PMCID: PMC9187954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma. J Clin Oncol. 2022 May 26; JCO2200219. Bootsma M, McKay RR, Emamekhoo H, Bade RM, Schehr JL, Mannino MC, Singh A, Wolfe SK, Schultz ZD, Sperger J, Xie W, Signoretti S, Kyriakopoulos CE, Kosoff D, Abel EJ, Helzer KT, Rydzewski N, Bakhtiar H, Shi Y, Blitzer G, Bassetti M, Floberg J, Yu M, Sethakorn N, Sharifi M, Harari PM, Choueiri TK, Lang JM, Zhao SG. PMID: 35617646.
      View in: PubMed   Mentions:    Fields:    
    9. Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell Carcinoma. Oncology (Williston Park). 2022 05 09; 36(5):316-320. Panian J, Pan E, Shi V, Hinds B, Mckay RR. PMID: 35576175.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry. Oncologist. 2022 05 06; 27(5):398-406. Borno HT, Kim MO, Hong JC, Yousefi S, Lin A, Tolstykh I, Zhang S, McKay RR, Harismendy O, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ. PMID: 35348771; PMCID: PMC9074994.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. Blood Cancer Discov. 2022 05 05; 3(3):181-193. Rubinstein SM, Bhutani D, Lynch RC, Hsu CY, Shyr Y, Advani S, Mesa RA, Mishra S, Mundt DP, Shah DP, Sica RA, Stockerl-Goldstein KE, Stratton C, Weiss M, Beeghly-Fadiel A, Accordino M, Assouline SE, Awosika J, Bakouny Z, Bashir B, Berg S, Bilen MA, Castellano CA, Cogan JC, Kc D, Friese CR, Gupta S, Hausrath D, Hwang C, Johnson NA, Joshi M, Kasi A, Klein EJ, Koshkin VS, Kuderer NM, Kwon DH, Labaki C, Latif T, Lau E, Li X, Lyman GH, McKay RR, Nagaraj G, Nizam A, Nonato TK, Olszewski AJ, Polimera HV, Portuguese AJ, Puc MM, Razavi P, Rosovski R, Schmidt A, Shah SA, Shastri A, Su C, Torka P, Wise-Draper TM, Zubiri L, Warner JL, Thompson MA, COVID-19 and Cancer Consortium. PMID: 35262738.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors. Clin Genitourin Cancer. 2022 08; 20(4):301-306. Nuzzo PV, Adib E, Weise N, Curran C, Stewart T, Freeman D, Nassar AH, Abou Alaiwi S, Bakouny Z, McGregor BA, Choueiri TK, Jain RK, McKay RR, Sonpavde G. PMID: 35614012.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials. Urol Oncol. 2022 05; 40(5):199.e15-199.e21. Javier-DesLoges J, Nelson TJ, Murphy JD, McKay RR, Stewart TF, Kader AK, Derweesh I, Martinez ME, Rose BS. PMID: 35431133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):600-608. Kotha NV, Kumar A, Qiao EM, Qian AS, Voora RS, Nalawade V, Karim Kader A, McKay RR, Stewart TF, Rose BS. PMID: 34918091; PMCID: PMC9002275.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry. Clin Genitourin Cancer. 2022 08; 20(4):326-333. Meagher MF, Mir MC, Autorino R, Minervini A, Kriegmair M, Maurer T, Porpiglia F, Van Bruwaene S, Linares E, Hevia V, Musquera M, Roussel E, Pavan N, Antonelli A, Zhang S, Ghali F, Patel D, Javier-Desloges J, Bradshaw A, Rubio J, Guruli G, Tracey A, Campi R, Albersen M, Furlan M, McKay RR, Derweesh IH. PMID: 35585014.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents. Adv Ther. 2022 06; 39(6):2515-2532. Hafron JM, Wilfehrt HM, Ferro C, Harmon M, Flanders SC, McKay RR. PMID: 35352309; PMCID: PMC9123060.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Germline alterations among Hispanic men with prostate cancer. Prostate Cancer Prostatic Dis. 2022 Sep; 25(3):561-567. Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. PMID: 35228665.
      View in: PubMed   Mentions:    Fields:    
    18. Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer. Urol Oncol. 2022 06; 40(6):274.e1-274.e6. Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Rose BS, Stewart TF. PMID: 35216893; PMCID: PMC8863428.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. SMART COVID Navigator, a Clinical Decision Support Tool for COVID-19 Treatment: Design and Development Study. J Med Internet Res. 2022 02 18; 24(2):e29279. Suraj V, Del Vecchio Fitz C, Kleiman LB, Bhavnani SK, Jani C, Shah S, McKay RR, Warner J, Alterovitz G. PMID: 34932493; PMCID: PMC8862760.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium. Lancet Healthy Longev. 2022 03; 3(3):e143-e152. Elkrief A, Hennessy C, Kuderer NM, Rubinstein SM, Wulff-Burchfield E, Rosovsky RP, Vega-Luna K, Thompson MA, Panagiotou OA, Desai A, Rivera DR, Khaki AR, Tachiki L, Lynch RC, Stratton C, Elias R, Batist G, Kasi A, Shah DP, Bakouny Z, Cabal A, Clement J, Crowell J, Dixon B, Friese CR, Fry SL, Grover P, Gulati S, Gupta S, Hwang C, Khan H, Kim SJ, Klein EJ, Labaki C, McKay RR, Nizam A, Pennell NA, Puc M, Schmidt AL, Shahrokni A, Shaya JA, Su CT, Wall S, Williams N, Wise-Draper TM, Mishra S, Grivas P, French B, Warner JL, Wildes TM, COVID-19 and Cancer Consortium. PMID: 35187516; PMCID: PMC8843069.
      View in: PubMed   Mentions: 2  
    21. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study. Open Forum Infect Dis. 2022 Mar; 9(3):ofac037. Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, Awosika J, Bakouny Z, Bashir B, Berg S, Bernardes M, Egan PC, Elkrief A, Feldman LE, Friese CR, Goel S, Gomez CG, Grant KL, Griffiths EA, Gulati S, Gupta S, Hwang C, Jain J, Jani C, Kaltsas A, Kasi A, Khan H, Knox N, Koshkin VS, Kwon DH, Labaki C, Lyman GH, McKay RR, McNair C, Nagaraj G, Nakasone ES, Nguyen R, Nonato TK, Olszewski AJ, Panagiotou OA, Puc M, Razavi P, Robilotti EV, Santos-Dutra M, Schmidt AL, Shah DP, Shah SA, Vieira K, Weissmann LB, Wise-Draper TM, Wu U, Wu JT, Choueiri TK, Mishra S, Warner JL, French B, Farmakiotis D. PMID: 35198648; PMCID: PMC8860152.
      View in: PubMed   Mentions: 1  
    22. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. JCO Precis Oncol. 2022 02; 6:e2100448. McGregor BA, Xie W, Adib E, Stadler WM, Zakharia Y, Alva A, Michaelson MD, Gupta S, Lam ET, Farah S, Nassar AH, Wei XX, Kilbridge KL, Harshman L, Signoretti S, Sholl L, Kwiatkowski DJ, McKay RR, Choueiri TK. PMID: 35171658; PMCID: PMC8865529.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    23. The renal clear cell carcinoma immune landscape. Neoplasia. 2022 02; 24(2):145-154. Saad OA, Li WT, Krishnan AR, Nguyen GC, Lopez JP, McKay RR, Wang-Rodriguez J, Ongkeko WM. PMID: 34991061; PMCID: PMC8740459.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    24. Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Netw Open. 2022 01 04; 5(1):e2142046. Hawley JE, Sun T, Chism DD, Duma N, Fu JC, Gatson NTN, Mishra S, Nguyen RH, Reid SA, Serrano OK, Singh SRK, Venepalli NK, Bakouny Z, Bashir B, Bilen MA, Caimi PF, Choueiri TK, Dawsey SJ, Fecher LA, Flora DB, Friese CR, Glover MJ, Gonzalez CJ, Goyal S, Halfdanarson TR, Hershman DL, Khan H, Labaki C, Lewis MA, McKay RR, Messing I, Pennell NA, Puc M, Ravindranathan D, Rhodes TD, Rivera AV, Roller J, Schwartz GK, Shah SA, Shaya JA, Streckfuss M, Thompson MA, Wulff-Burchfield EM, Xie Z, Yu PP, Warner JL, Shah DP, French B, Hwang C, COVID-19 and Cancer Consortium (CCC19). PMID: 34982158; PMCID: PMC8728628.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    25. Impact of age on treatment response in men with prostate cancer treated with radiotherapy. BJUI Compass. 2022 May; 3(3):243-250. Bryant AK, Nelson TJ, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Sandhu AP, Mundt AJ, Murphy JD, Rose BS. PMID: 35492227; PMCID: PMC9045578.
      View in: PubMed   Mentions: 2  
    26. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol. 2022 03; 33(3):340-346. Schmidt AL, Labaki C, Hsu CY, Bakouny Z, Balanchivadze N, Berg SA, Blau S, Daher A, El Zarif T, Friese CR, Griffiths EA, Hawley JE, Hayes-Lattin B, Karivedu V, Latif T, Mavromatis BH, McKay RR, Nagaraj G, Nguyen RH, Panagiotou OA, Portuguese AJ, Puc M, Santos Dutra M, Schroeder BA, Thakkar A, Wulff-Burchfield EM, Mishra S, Farmakiotis D, Shyr Y, Warner JL, Choueiri TK, COVID-19 and Cancer Consortium. PMID: 34958894; PMCID: PMC8704021.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    27. Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin. Clin Genitourin Cancer. 2022 04; 20(2):165-175. Talukder R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lorenzo GD, Joshi M, Velho PI, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR. PMID: 35078711; PMCID: PMC8995351.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Analysis of CDK12 alterations in a pan-cancer database. Cancer Med. 2022 02; 11(3):753-763. Pan E, Cabal A, Javier-DesLoges J, Patel D, Panian J, Lee S, Shaya J, Nonato T, Xu X, Stewart T, Rose B, Shabaik A, Cohen E, Kurzrock R, Tamayo P, McKay RR. PMID: 34898046; PMCID: PMC8817093.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. Cancer Discov. 2022 02; 12(2):303-330. Elkrief A, Wu JT, Jani C, Enriquez KT, Glover M, Shah MR, Shaikh HG, Beeghly-Fadiel A, French B, Jhawar SR, Johnson DB, McKay RR, Rivera DR, Reuben DY, Shah S, Tinianov SL, Vinh DC, Mishra S, Warner JL. PMID: 34893494; PMCID: PMC8831477.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    30. Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma. JAMA Oncol. 2021 Dec 01; 7(12):1815-1823. Hirsch L, Martinez Chanza N, Farah S, Xie W, Flippot R, Braun DA, Rathi N, Thouvenin J, Collier KA, Seront E, de Velasco G, Dzimitrowicz H, Beuselinck B, Xu W, Bowman IA, Lam ET, Abuqayas B, Bilen MA, Varkaris A, Zakharia Y, Harrison MR, Mortazavi A, Barthélémy P, Agarwal N, McKay RR, Brastianos PK, Krajewski KM, Albigès L, Harshman LC, Choueiri TK. PMID: 34673916; PMCID: PMC8532040.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. Cancer. 2022 02 15; 128(4):770-777. Javier-DesLoges J, Nelson TJ, Murphy JD, McKay RR, Pan E, Parsons JK, Kane CJ, Kader AK, Derweesh IH, Nodora J, Patel SP, Martinez ME, Rose BS. PMID: 34806168.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Disparities in germline testing among racial minorities with prostate cancer. Prostate Cancer Prostatic Dis. 2022 Sep; 25(3):403-410. Weise N, Shaya J, Javier-Desloges J, Cheng HH, Madlensky L, McKay RR. PMID: 34775478; PMCID: PMC8590439.
      View in: PubMed   Mentions: 2     Fields:    
    33. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19. JAMA Netw Open. 2021 11 01; 4(11):e2134330. Schmidt AL, Tucker MD, Bakouny Z, Labaki C, Hsu CY, Shyr Y, Armstrong AJ, Beer TM, Bijjula RR, Bilen MA, Connell CF, Dawsey SJ, Faller B, Gao X, Gartrell BA, Gill D, Gulati S, Halabi S, Hwang C, Joshi M, Khaki AR, Menon H, Morris MJ, Puc M, Russell KB, Shah NJ, Sharifi N, Shaya J, Schweizer MT, Steinharter J, Wulff-Burchfield EM, Xu W, Zhu J, Mishra S, Grivas P, Rini BI, Warner JL, Zhang T, Choueiri TK, Gupta S, McKay RR. PMID: 34767021; PMCID: PMC8590166.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. Asymptomatic detection of SARS-CoV-2 among cancer patients receiving infusional anti-cancer therapy. Cancer Med. 2021 12; 10(24):8763-8767. Shaya J, Cabal A, Nonato T, Torriani F, Califano J, Lippman S, Sacco A, McKay RR. PMID: 34708934; PMCID: PMC8646446.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    35. Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation. Adv Radiat Oncol. 2022 Jan-Feb; 7(1):100836. Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Stewart TF, Rose BS. PMID: 35071834; PMCID: PMC8767252.
      View in: PubMed   Mentions:
    36. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study. Genome Med. 2021 10 04; 13(1):155. Sicklick JK, Kato S, Okamura R, Patel H, Nikanjam M, Fanta PT, Hahn ME, De P, Williams C, Guido J, Solomon BM, McKay RR, Krie A, Boles SG, Ross JS, Lee JJ, Leyland-Jones B, Lippman SM, Kurzrock R. PMID: 34607609; PMCID: PMC8491393.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. BJU Int. 2021 Oct 01. Makrakis D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR. PMID: 34597472.
      View in: PubMed   Mentions:    Fields:    
    38. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men. J Natl Cancer Inst. 2021 10 01; 113(10):1343-1351. Klebaner D, Courtney PT, Garraway IP, Einck J, Kumar A, Martinez ME, McKay R, Murphy JD, Parada H, Sandhu A, Stewart T, Yamoah K, Rose BS. PMID: 33892497; PMCID: PMC8486332.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer. Cell Rep. 2021 09 07; 36(10):109665. Tewari AK, Cheung ATM, Crowdis J, Conway JR, Camp SY, Wankowicz SA, Livitz DG, Park J, Lis RT, Bosma-Moody A, He MX, AlDubayan SH, Zhang Z, McKay RR, Leshchiner I, Brown M, Balk SP, Getz G, Taplin ME, Van Allen EM. PMID: 34496240.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study. J Clin Oncol. 2021 11 20; 39(33):3725-3736. Pal SK, McGregor B, Suárez C, Tsao CK, Kelly W, Vaishampayan U, Pagliaro L, Maughan BL, Loriot Y, Castellano D, Srinivas S, McKay RR, Dreicer R, Hutson T, Dubey S, Werneke S, Panneerselvam A, Curran D, Scheffold C, Choueiri TK, Agarwal N. PMID: 34491815; PMCID: PMC8601305.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    41. The Promise of Adjuvant Immunotherapy in Renal-Cell Carcinoma. N Engl J Med. 2021 08 19; 385(8):756-758. McKay RR. PMID: 34407348.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 10; 19(10):2522-2532. Li A, Kuderer NM, Hsu CY, Shyr Y, Warner JL, Shah DP, Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP, CCC19 consortium. PMID: 34260813; PMCID: PMC8420489.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    43. PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. Prostate Cancer Prostatic Dis. 2021 Aug 06. Koshkin VS, Patel VG, Ali A, Bilen MA, Ravindranathan D, Park JJ, Kellezi O, Cieslik M, Shaya J, Cabal A, Brown L, Labriola M, Graham LS, Pritchard C, Tripathi A, Nusrat S, Barata P, Jang A, Chen SR, Garje R, Acharya L, Hwang C, Pilling A, Oh W, Jun T, Natesan D, Nguyen C, Kilari D, Pierro M, Thapa B, Cackowski F, Mack A, Heath E, Marshall CH, Tagawa ST, Halabi S, Schweizer MT, Armstrong A, Dorff T, Alva A, McKay R. PMID: 34363009.
      View in: PubMed   Mentions: 5     Fields:    
    44. Analysis of the Prognostic Significance of Circulating Tumor DNA in Metastatic Castrate Resistant Prostate Cancer. Clin Genitourin Cancer. 2021 12; 19(6):564.e1-564.e10. Shaya J, Nonato T, Cabal A, Randall JM, Millard F, Stewart T, McKay RR. PMID: 34452870.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. The microbiome and prostate cancer. Prostate Cancer Prostatic Dis. 2022 02; 25(2):159-164. Javier-DesLoges J, McKay RR, Swafford AD, Sepich-Poore GD, Knight R, Parsons JK. PMID: 34267333; PMCID: PMC8767983.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer. J Clin Oncol. 2021 09 10; 39(26):2926-2937. Sperger JM, Emamekhoo H, McKay RR, Stahlfeld CN, Singh A, Chen XE, Kwak L, Gilsdorf CS, Wolfe SK, Wei XX, Silver R, Zhang Z, Morris MJ, Bubley G, Feng FY, Scher HI, Rathkopf D, Dehm SM, Choueiri TK, Halabi S, Armstrong AJ, Wyatt AW, Taplin ME, Zhao SG, Lang JM. PMID: 34197212; PMCID: PMC8425833.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    47. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans. Eur Urol Open Sci. 2021 Aug; 30:1-10. Kumar A, Cherry DR, Courtney PT, Nalawade V, Kotha N, Riviere PJ, Efstathiou J, McKay RR, Karim Kader A, Rose BS, Stewart TF. PMID: 34337540; PMCID: PMC8317783.
      View in: PubMed   Mentions: 1  
    48. Cardiovascular toxicities associated with abiraterone compared to enzalutamide-A pharmacovigilance study. EClinicalMedicine. 2021 Jun; 36:100887. Cone EB, Reese S, Marchese M, Nabi J, McKay RR, Kilbridge KL, Trinh QD. PMID: 34308305; PMCID: PMC8257986.
      View in: PubMed   Mentions:
    49. Resistance to COVID-19 vaccination has increased in Ireland and the United Kingdom during the pandemic. Public Health. 2021 Jun; 195:54-56. Hyland P, Vallières F, Shevlin M, Bentall RP, McKay R, Hartman TK, McBride O, Murphy J. PMID: 34052508; PMCID: PMC8075808.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    50. Redefining the Clinical States of Prostate Cancer in the Modern Era. Oncology (Williston Park). 2021 04 20; 35(4):169. McKay R. PMID: 33877748.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer. Eur Urol. 2021 09; 80(3):295-303. Berchuck JE, Zhang Z, Silver R, Kwak L, Xie W, Lee GM, Freedman ML, Kibel AS, Van Allen EM, McKay RR, Taplin ME. PMID: 33888356.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    52. Prognostic Significance of Pancreatic Metastases in Patients With Advanced Renal Cell Carcinoma Treated With Systemic Therapy. Clin Genitourin Cancer. 2021 12; 19(6):e367-e373. Shaya JA, Lin X, Weise N, Cabal A, Panian J, Derweesh IH, McKay RR. PMID: 34176762.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. Clin Cancer Res. 2021 07 01; 27(13):3610-3619. McKay RR, Kwak L, Crowdis JP, Sperger JM, Zhao SG, Xie W, Werner L, Lis RT, Zhang Z, Wei XX, Lang JM, Van Allen EM, Bhatt RS, Yu EY, Nelson PS, Bubley GJ, Montgomery RB, Taplin ME. PMID: 33849963; PMCID: PMC8254786.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    54. Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry. JCO Glob Oncol. 2021 04; 7:495-505. McKay RR, Gold T, Zarif JC, Chowdhury-Paulino IM, Friedant A, Gerke T, Grant M, Hawthorne K, Heath E, Huang FW, Jackson MD, Mahal B, Ogbeide O, Paich K, Ragin C, Rencsok EM, Simmons S, Yates C, Vinson J, Kantoff PW, George DJ, Mucci LA. PMID: 33835826; PMCID: PMC8162521.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Prostate. 2021 05; 81(7):433-439. Ledet EM, Burgess EF, Sokolova AO, Jaeger EB, Hatton W, Moses M, Miller P, Cotogno P, Layton J, Barata P, Lewis BE, Nakazawa M, Zhu J, Dellinger B, Elrefai S, Nafissi NN, Egan JB, Shore N, McKay RR, Bryce AH, Cheng HH, Antonarakis ES, Sartor O. PMID: 33792945; PMCID: PMC8252583.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S. Oncologist. 2021 05; 26(5):e905-e906. Paciotti M, Schmidt AL, Ravi P, McKay RR, Trinh QD, Choueiri TK. PMID: 33650184; PMCID: PMC8100555.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 06; 32(6):787-800. Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. PMID: 33746047; PMCID: PMC7972830.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCellsPHPublic Health
    58. Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer. J Urol. 2021 07; 206(1):80-87. McKay RR, Xie W, Ye H, Fennessy FM, Zhang Z, Lis R, Calagua C, Rathkopf D, Laudone VP, Bubley GJ, Einstein DJ, Chang PK, Wagner AA, Parsons JK, Preston MA, Kilbridge K, Chang SL, Choudhury AD, Pomerantz MM, Trinh QD, Kibel AS, Taplin ME. PMID: 33683939.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    59. Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma. Mol Oncol. 2021 09; 15(9):2330-2344. Bade RM, Schehr JL, Emamekhoo H, Gibbs BK, Rodems TS, Mannino MC, Desotelle JA, Heninger E, Stahlfeld CN, Sperger JM, Singh A, Wolfe SK, Niles DJ, Arafat W, Steinharter JA, Jason Abel E, Beebe DJ, Wei XX, McKay RR, Choueri TK, Lang JM. PMID: 33604999; PMCID: PMC8410529.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    60. Next Steps: Sequencing Therapies in Metastatic Kidney Cancer in the Contemporary Era. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:1-11. Schmidt AL, Tabakin AL, Singer EA, Choueiri TK, McKay RR. PMID: 33793313.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. BJU Int. 2021 08; 128(2):196-205. Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P. PMID: 33556233.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. J Natl Compr Canc Netw. 2021 02 02; 19(2):134-143. Schaeffer E, Srinivas S, Antonarakis ES, Armstrong AJ, Bekelman JE, Cheng H, D'Amico AV, Davis BJ, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Horwitz EM, Ippolito JE, Kuettel MR, Lang JM, McKay R, McKenney J, Netto G, Penson DF, Pow-Sang JM, Reiter R, Richey S, Roach Iii M, Rosenfeld S, Shabsigh A, Spratt DE, Teply BA, Tward J, Shead DA, Freedman-Cass DA. PMID: 33545689.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    63. Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials. J Urol. 2021 06; 205(6):1689-1697. McKay RR, Berchuck J, Kwak L, Xie W, Silver R, Bubley GJ, Chang PK, Wagner A, Zhang Z, Kibel AS, Taplin ME. PMID: 33502237.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma. Sci Transl Med. 2021 01 20; 13(577). Khanna P, Soh HJ, Chen CH, Saxena R, Amin S, Naughton M, Joslin PN, Moore A, Bakouny Z, O'Callaghan C, Catalano P, Signoretti S, McKay R, Choueiri TK, Bhasin M, Walther T, Bhatt RS. PMID: 33472951.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    65. Streamlining Germline Genetic Testing in Prostate Cancer. Eur Urol Oncol. 2021 02; 4(1):10-11. McKay RR, Antonarakis ES. PMID: 33483264.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    66. Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer. 2021 03 15; 127(6):840-849. McGregor BA, Campbell MT, Xie W, Farah S, Bilen MA, Schmidt AL, Sonpavde GP, Kilbridge KL, Choudhury AD, Mortazavi A, Shah AY, Venkatesan AM, Bubley GJ, Siefker-Radtke AO, McKay RR, Choueiri TK. PMID: 33216356.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    67. Accelerating precision medicine in metastatic prostate cancer. Nat Cancer. 2020 11; 1(11):1041-1053. Mateo J, McKay R, Abida W, Aggarwal R, Alumkal J, Alva A, Feng F, Gao X, Graff J, Hussain M, Karzai F, Montgomery B, Oh W, Patel V, Rathkopf D, Rettig M, Schultz N, Smith M, Solit D, Sternberg C, Van Allen E, VanderWeele D, Vinson J, Soule HR, Chinnaiyan A, Small E, Simons JW, Dahut W, Miyahira AK, Beltran H. PMID: 34258585; PMCID: PMC8274325.
      View in: PubMed   Mentions: 12  Translation:Humans
    68. Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE). J Clin Oncol. 2020 12 20; 38(36):4240-4248. McKay RR, McGregor BA, Xie W, Braun DA, Wei X, Kyriakopoulos CE, Zakharia Y, Maughan BL, Rose TL, Stadler WM, McDermott DF, Harshman LC, Choueiri TK. PMID: 33108238; PMCID: PMC7768333.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    69. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021 02 01; 127(3):403-411. McKay RR, Sarkar RR, Kumar A, Einck JP, Garraway IP, Lynch JA, Mundt AJ, Murphy JD, Stewart TF, Yamoah K, Rose BS. PMID: 33036065.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer. Adv Ther. 2020 12; 37(12):4910-4929. McKay RR, Hafron JM, Ferro C, Wilfehrt HM, Fitch K, Flanders SC, Fabrizio MD, Schweizer MT. PMID: 33029725; PMCID: PMC7596004.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma. JAMA Oncol. 2020 10 01; 6(10):1606-1610. Ravi P, Mantia C, Su C, Sorenson K, Elhag D, Rathi N, Bakouny Z, Agarwal N, Zakharia Y, Costello BA, McKay RR, Narayan V, Alva A, McGregor BA, Gao X, McDermott DF, Choueiri TK. PMID: 32469396; PMCID: PMC7260689.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    72. Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign? CA Cancer J Clin. 2021 01; 71(1):34-46. Cinar P, Bold R, Bosslet BA, Bota DA, Burgess D, Chew HK, Cohen JG, Elquza E, Gold KA, Kamiya E, Karlan BY, McKay RR, Patel SP, Ternavan K, Welborn J, Yamamoto M, Rugo HS. PMID: 32997807; PMCID: PMC7537198.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    73. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC. JCO Oncol Pract. 2020 12; 16(12):811-819. Szymaniak BM, Facchini LA, Giri VN, Antonarakis ES, Beer TM, Carlo MI, Danila DC, Dhawan M, George D, Graff JN, Gupta S, Heath E, Higano CS, Liu G, Molina AM, Paller CJ, Patnaik A, Petrylak DP, Reichert Z, Rettig MB, Ryan CJ, Taplin ME, Vinson J, Whang YE, Morgans AK, Cheng HH, McKay RR. PMID: 32986533; PMCID: PMC7735040.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    74. Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma. J Urol. 2021 02; 205(2):414-419. Wei XX, Werner L, Teo MY, Rosenberg JE, Koshkin VS, Grivas P, Szabados B, Morrison L, Powles T, Carril-Ajuria L, Castellano D, Velho PI, Hahn NM, McKay RR, Raggi D, Necchi A, Kanesvaran R, Alerasool P, Gaines J, Galsky M, Bellmunt J, Sonpavde G. PMID: 32935617; PMCID: PMC8715311.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Immunotherapy for Localized Prostate Cancer: The Next Frontier? Urol Clin North Am. 2020 Nov; 47(4):443-456. Patel D, McKay R, Parsons JK. PMID: 33008495.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center. Prostate Cancer Prostatic Dis. 2021 03; 24(1):210-219. McKay RR, Silver R, Bhak RH, Korves C, Cheng M, Appukkuttan S, Simmons SJ, Duh MS, Taplin ME. PMID: 32814846; PMCID: PMC8012208.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer. JCO Glob Oncol. 2020 08; 6:1248-1257. Ürün Y, Hussain SA, Bakouny Z, Castellano D, Kiliçkap S, Morgan G, Mckay RR, Pels K, Schmidt A, Doroshow DB, Schütz F, Albiges L, Lopes G, Catto JWF, Peters S, Choueiri TK. PMID: 32755479; PMCID: PMC7456315.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    78. Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease. Prostate Cancer Prostatic Dis. 2020 12; 23(4):689-695. Sarkar RR, Patel SH, Parsons JK, Deka R, Kumar A, Einck JP, Mundt AJ, Kader AK, Kane CJ, Riviere P, McKay R, Murphy JD, Rose BS. PMID: 32513967.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions. Cancer Epidemiol Biomarkers Prev. 2020 07; 29(7):1374-1380. Rencsok EM, Bazzi LA, McKay RR, Huang FW, Friedant A, Vinson J, Peisch S, Zarif JC, Simmons S, Hawthorne K, Villanti P, Kantoff PW, Heath E, George DJ, Mucci LA. PMID: 32503813; PMCID: PMC7334076.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    80. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 06 20; 395(10241):1907-1918. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL, COVID-19 and Cancer Consortium. PMID: 32473681; PMCID: PMC7255743.
      View in: PubMed   Mentions: 626     Fields:    Translation:HumansCellsPHPublic Health
    81. Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions. Am Soc Clin Oncol Educ Book. 2020 May; 40:1-12. McKay RR, Feng FY, Wang AY, Wallis CJD, Moses KA. PMID: 32412803.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    82. Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma. Genet Med. 2020 08; 22(8):1366-1373. Lasseter K, Nassar AH, Hamieh L, Berchuck JE, Nuzzo PV, Korthauer K, Shinagare AB, Ogorek B, McKay R, Thorner AR, Lee GM, Braun DA, Bhatt RS, Freedman M, Choueiri TK, Kwiatkowski DJ. PMID: 32341571.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    83. CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade. JCO Precis Oncol. 2020; 4:382-392. Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A. PMID: 32671317; PMCID: PMC7363399.
      View in: PubMed   Mentions: 16     Fields:    
    84. The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy. Clin Genitourin Cancer. 2020 10; 18(5):e598-e609. Panian J, Lin X, Simantov R, Derweesh I, Choueiri TK, McKay RR. PMID: 32280027.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020 03; 579(7800):567-574. Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf J, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Knight R. PMID: 32214244; PMCID: PMC7500457.
      View in: PubMed   Mentions: 177     Fields:    Translation:Humans
    86. Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study. J Immunother Cancer. 2020 03; 8(1). Martinez Chanza N, Xie W, Issa M, Dzimitrowicz H, Tripathi A, Beuselinck B, Lam E, Zakharia Y, Mckay R, Shah S, Mortazavi A, R Harrison M, Sideris S, Kaymakcalan MD, Abou Alaiwi S, Nassar AH, Nuzzo PV, Hamid A, K Choueiri T, C Harshman L. PMID: 32217762; PMCID: PMC7174076.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    87. Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts. JCO Glob Oncol. 2020 02; 6:293-306. Bossé D, Xie W, Lin X, Simantov R, Lalani AA, Graham J, Wells JC, Donskov F, Rini B, Beuselinck B, Alva A, Hansen A, Wood L, Soulières D, Kollmannsberger C, Patenaude F, Heng DYC, Choueiri TK, McKay RR. PMID: 32109159; PMCID: PMC7055470.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. Neoadjuvant Approaches Prior To Radical Prostatectomy. Cancer J. 2020 Jan/Feb; 26(1):2-12. Ryan ST, Patel DN, Parsons JK, McKay RR. PMID: 31977379.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 08; 18(4):e350-e359. Wells JC, Graham J, Beuselinck B, Bjarnason GA, Donskov F, Hansen AR, McKay RR, Vaishampayan U, De Velasco G, Duh MS, Huynh L, Nguyen C, Zanotti G, Ramaswamy K, Choueiri TK, Heng DYC. PMID: 31926879.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    90. Immunotherapy combinations transform the treatment paradigm for advanced renal cell carcinoma. Ann Transl Med. 2019 Dec; 7(Suppl 8):S385. Shaya JA, McKay RR. PMID: 32016103; PMCID: PMC6976508.
      View in: PubMed   Mentions:
    91. Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy. J Natl Compr Canc Netw. 2019 12; 17(12):1497-1504. Vitzthum LK, Straka C, Sarkar RR, McKay R, Randall JM, Sandhu A, Murphy JD, Rose BS. PMID: 31805534.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors. Eur Urol Oncol. 2021 02; 4(1):102-111. Graham J, Shah AY, Wells JC, McKay RR, Vaishampayan U, Hansen A, Donskov F, Bjarnason GA, Beuselinck B, De Velasco G, Iafolla M, Duh MS, Huynh L, Chang R, Zanotti G, Ramaswamy K, Choueiri TK, Tannir NM, Heng DYC. PMID: 31786162.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    93. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. Urol Oncol. 2020 03; 38(3):83-93. Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. PMID: 31734020.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    94. Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features. J Clin Oncol. 2020 01 01; 38(1):63-70. McGregor BA, McKay RR, Braun DA, Werner L, Gray K, Flaifel A, Signoretti S, Hirsch MS, Steinharter JA, Bakouny Z, Flippot R, Wei XX, Choudhury A, Kilbridge K, Freeman GJ, Van Allen EM, Harshman LC, McDermott DF, Vaishampayan U, Choueiri TK. PMID: 31721643; PMCID: PMC7051851.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    95. Management of bone complications in patients with genitourinary malignancies. Urol Oncol. 2020 03; 38(3):94-104. Ballon-Landa E, Panian J, Derweesh IH, McKay RR. PMID: 31676279.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. Response of Primary Renal Cell Carcinoma to Systemic Therapy. Eur Urol. 2019 12; 76(6):852-860. Bossé D, Lin X, Simantov R, Lalani AA, Derweesh I, Chang SL, Choueiri TK, McKay RR. PMID: 31594707.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma. Eur Urol Oncol. 2020 06; 3(3):372-381. Lalani AA, Xie W, Braun DA, Kaymakcalan M, Bossé D, Steinharter JA, Martini DJ, Simantov R, Lin X, Wei XX, McGregor BA, McKay RR, Harshman LC, Choueiri TK. PMID: 31562048; PMCID: PMC9163676.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    98. The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2019 12; 17(6):443-450.e1. McKay RR, Vu P, Albiges LK, Lin X, Simantov R, Temel JS, Choueiri TK. PMID: 31601515.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Clinical implications of genetic aberrations in metastatic prostate cancer. Curr Opin Urol. 2019 07; 29(4):319-325. Reichert ZR, McKay RR. PMID: 31158106.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies. Eur Urol Focus. 2020 01 15; 6(1):17-25. Patel SH, Panian J, Bree K, Derweesh I, Millard F, Randall J, Mckay R. PMID: 31255618.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    101. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer. JAMA Intern Med. 2019 06 01; 179(6):812-819. Sarkar RR, Parsons JK, Bryant AK, Ryan ST, Kader AK, McKay RR, D'Amico AV, Nguyen PL, Hulley BJ, Einck JP, Mundt AJ, Kane CJ, Murphy JD, Rose BS. PMID: 31058923; PMCID: PMC6503564.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    102. Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial. J Med Internet Res. 2019 05 02; 21(5):e12044. McKay R, Mills H, Werner L, Choudhury A, Choueiri T, Jacobus S, Pace A, Polacek L, Pomerantz M, Prisby J, Sweeney C, Walsh M, Taplin ME. PMID: 31045501; PMCID: PMC6538310.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    103. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. Clin Genitourin Cancer. 2019 08; 17(4):275-282.e1. Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN, PCCTC Germline Genetics Working Group. PMID: 31171481; PMCID: PMC6662206.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    104. Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma. Cancers (Basel). 2019 Apr 15; 11(4). Yim K, Bindayi A, McKay R, Mehrazin R, Raheem OA, Field C, Bloch A, Wake R, Ryan S, Patterson A, Derweesh IH. PMID: 30991671; PMCID: PMC6520981.
      View in: PubMed   Mentions: 7  
    105. Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy. Prostate Cancer Prostatic Dis. 2019 12; 22(4):600-608. Deka R, Simpson DR, Panizzon MS, Hauger RL, Riviere P, Nalawade V, McKay R, Murphy JD, Rose BS. PMID: 30988408.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    106. Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives. Int J Urol. 2019 05; 26(5):532-542. Berquist SW, Yim K, Ryan ST, Patel SH, Eldefrawy A, Cotta BH, Bradshaw AW, Meagher MF, Bindayi A, McKay RR, Autorino R, Staehler M, Derweesh IH. PMID: 30943578.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    107. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Lancet Oncol. 2019 04; 20(4):581-590. Martínez Chanzá N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC. PMID: 30827746; PMCID: PMC6849381.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    108. Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. J Clin Oncol. 2019 04 10; 37(11):923-931. McKay RR, Ye H, Xie W, Lis R, Calagua C, Zhang Z, Trinh QD, Chang SL, Harshman LC, Ross AE, Pienta KJ, Lin DW, Ellis WJ, Montgomery B, Chang P, Wagner AA, Bubley GJ, Kibel AS, Taplin ME. PMID: 30811282; PMCID: PMC7051849.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    109. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy. Cancer. 2019 04 01; 125(7):1070-1080. Deka R, Rose BS, Bryant AK, Sarkar RR, Nalawade V, McKay R, Murphy JD, Simpson DR. PMID: 30748008.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    110. Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis. Clin Genitourin Cancer. 2019 06; 17(3):e505-e512. Field CA, Cotta BH, Jimenez J, Lane BR, Yim K, Lee HJ, Ryan ST, Hamilton ZA, Patel S, Wang S, Kane CJ, Dey S, Mckay RR, Noyes S, Millard FE, Rini BI, Campbell SC, Derweesh IH. PMID: 30808547.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    111. Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1068-1076. Bryant AK, McKay RR, Kader AK, Parsons JK, Einck JP, Kane CJ, Mundt AJ, Murphy JD, Rose BS. PMID: 30543857.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer. Cancer. 2019 02 15; 125(4):524-532. McKay RR, Werner L, Jacobus SJ, Jones A, Mostaghel EA, Marck BT, Choudhury AD, Pomerantz MM, Sweeney CJ, Slovin SF, Morris MJ, Kantoff PW, Taplin ME. PMID: 30427533; PMCID: PMC6353689.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    113. Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy. JAMA Oncol. 2018 11 01; 4(11):1616-1617. Deka R, Simpson DR, Bryant AK, Nalawade V, McKay R, Murphy JD, Rose BS. PMID: 30325986; PMCID: PMC6248075.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    114. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. 2019 02; 79(3):244-258. Miyahira AK, Den RB, Carlo MI, de Leeuw R, Hope TA, Karzai F, McKay RR, Salami SS, Simons JW, Pienta KJ, Soule HR. PMID: 30381857.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    115. Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma. J Clin Oncol. 2018 10 29; JCO2018790253. McKay RR, Bossé D, Choueiri TK. PMID: 30372392.
      View in: PubMed   Mentions: 24     Fields:    
    116. Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer. Eur Urol Oncol. 2019 09; 2(5):584-588. Sarkar RR, Bryant AK, Parsons JK, Ryan ST, Karim Kader A, Kane CJ, McKay RR, Sandhu A, Murphy JD, Rose BS. PMID: 31411995; PMCID: PMC6697241.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    117. Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database. J Glob Oncol. 2018 09; 4:1-14. Fay AP, McKay RR, Lin X, Simantov R, Choueiri TK. PMID: 30241151; PMCID: PMC6223429.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    118. Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. JCO Precis Oncol. 2018; 2018. Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH. PMID: 30761386; PMCID: PMC6370313.
      View in: PubMed   Mentions: 11     Fields:    
    119. Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases. Clin Cancer Res. 2018 09 01; 24(17):4081-4088. McKay RR, Bossé D, Gray KP, Michaelson MD, Krajewski K, Jacene HA, Walsh M, Bellmunt J, Pomerantz M, Harshman LC, Choueiri TK. PMID: 29848570; PMCID: PMC6688176.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    120. The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma. Cancer Immunol Res. 2018 07; 6(7):758-765. McKay RR, Bossé D, Xie W, Wankowicz SAM, Flaifel A, Brandao R, Lalani AA, Martini DJ, Wei XX, Braun DA, Van Allen E, Castellano D, De Velasco G, Wells JC, Heng DY, Fay AP, Schutz FA, Hsu J, Pal SK, Lee JL, Hsieh JJ, Harshman LC, Signoretti S, Motzer RJ, Feldman D, Choueiri TK. PMID: 29748390; PMCID: PMC6712567.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    121. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy. Cancer. 2018 07 15; 124(14):2939-2947. Bryant AK, D'Amico AV, Nguyen PL, Einck JP, Kane CJ, McKay RR, Simpson DR, Mundt AJ, Murphy JD, Rose BS. PMID: 29727915.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    122. Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma. Clin Genitourin Cancer. 2018 10; 16(5):341-348. Gao X, Jegede O, Gray C, Catalano PJ, Novak J, Kwiatkowski DJ, McKay RR, George DJ, Choueiri TK, McDermott DF, Signoretti S, Bhatt RS. PMID: 29754934; PMCID: PMC6175670.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    123. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1188-1193. Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. PMID: 29891203.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    124. Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events. Cancer Immunol Res. 2018 04; 6(4):402-408. Martini DJ, Hamieh L, McKay RR, Harshman LC, Brandao R, Norton CK, Steinharter JA, Krajewski KM, Gao X, Schutz FA, McGregor B, Bossé D, Lalani AA, De Velasco G, Michaelson MD, McDermott DF, Choueiri TK. PMID: 29437040.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    125. Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade. Prostate Cancer Prostatic Dis. 2018 09; 21(3):364-372. McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, Preston MA, Trinh QD, Chang P, Wagner AA, Mostaghel EA, Kantoff PW, Nelson PS, Kibel AS, Taplin ME. PMID: 29263420; PMCID: PMC6013399.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    126. Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate Cancer. JCO Precis Oncol. 2017; 1. Han GC, Hwang J, Wankowicz SAM, Zhang Z, Liu D, Cibulskis C, Gaviola GC, Ghazikhanian V, McKay RR, Bubley GJ, Carter SL, Balk SP, Hahn WC, Taplin ME, Van Allen EM. PMID: 32913968; PMCID: PMC7446377.
      View in: PubMed   Mentions: 6     Fields:    
    127. The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases. Clin Genitourin Cancer. 2018 04; 16(2):e327-e333. Viteri Malone MA, Ares GR, De Velasco G, Brandão R, Lin X, Norton C, Simantov R, Moslehi J, Krajewski KM, Choueiri TK, McKay RR. PMID: 29361425.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    128. Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter Analysis. Clin Genitourin Cancer. 2018 04; 16(2):e289-e295. McDonald ML, Lane BR, Jimenez J, Lee HJ, Yim K, Bindayi A, Hamilton ZA, Field CA, Bloch AS, Dey S, Noyes S, McKay R, Millard F, Rini BI, Campbell SC, Derweesh IH. PMID: 29113767.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    129. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. Eur J Endocrinol. 2017 Nov; 177(5):439-444. Else T, Lerario AM, Everett J, Haymon L, Wham D, Mullane M, Wilson TL, Rainville I, Rana H, Worth AJ, Snyder NW, Blair IA, McKay R, Kilbridge K, Hammer G, Barletta J, Vaidya A. PMID: 28819017.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    130. Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database. Clin Genitourin Cancer. 2017 Aug 12. Hamieh L, McKay RR, Lin X, Simantov R, Choueiri TK. PMID: 28918175.
      View in: PubMed   Mentions:    Fields:    
    131. Neoadjuvant therapy for localized and locally advanced renal cell carcinoma. Urol Oncol. 2018 01; 36(1):31-37. Bindayi A, Hamilton ZA, McDonald ML, Yim K, Millard F, McKay RR, Campbell SC, Rini BI, Derweesh IH. PMID: 28802883.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    132. The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. Prostate. 2017 May; 77(13):1303-1311. Harshman LC, Werner L, Tripathi A, Wang X, Maughan BL, Antonarakis ES, Nakabayashi M, McKay R, Pomerantz M, Mucci LA, Taplin ME, Sweeney CJ, Lee GM, Kantoff PW. PMID: 28762529; PMCID: PMC5811259.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    133. Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2017 12; 15(6):724-732. Lalani AA, McKay RR, Lin X, Simantov R, Kaymakcalan MD, Choueiri TK. PMID: 28645482.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    134. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials. Clin Genitourin Cancer. 2017 12; 15(6):652-660.e1. de Velasco G, McKay RR, Lin X, Moreira RB, Simantov R, Choueiri TK. PMID: 28410911.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    135. Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases. Prostate Cancer Prostatic Dis. 2017 09; 20(3):276-282. McKay R, Haider B, Duh MS, Valderrama A, Nakabayashi M, Fiorillo M, Ristovska L, Wen L, Kantoff P. PMID: 28220804.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    136. Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK.Cancer. 2015 Oct 1;121(19):3435-43. [Epub 2015 Jun 8]. doi: 10.1002/cncr.29503. Urol Oncol. 2017 03; 35(3):117-118. Jay R, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK. PMID: 28159495.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    137. Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 08; 15(4):463-471. McKay RR, Werner L, Fiorillo M, Roberts J, Heath EI, Bubley GJ, Montgomery RB, Taplin ME. PMID: 27890446; PMCID: PMC6853188.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    138. Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations. J Clin Oncol. 2016 Oct 20; 34(30):3655-3663. Albiges L, Hakimi AA, Xie W, McKay RR, Simantov R, Lin X, Lee JL, Rini BI, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN, Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup AJ, Furberg H, Fay AP, de Velasco G, Preston MA, Wilson KM, Cho E, McDermott DF, Signoretti S, Heng DYC, Choueiri TK. PMID: 27601543; PMCID: PMC5065111.
      View in: PubMed   Mentions: 60     Fields:    
    139. A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2017 Feb 15; 23(4):935-945. McKay RR, Werner L, Mostaghel EA, Lis R, Voznesensky O, Zhang Z, Marck BT, Matsumoto AM, Domachevsky L, Zukotynski KA, Bhasin M, Bubley GJ, Montgomery B, Kantoff PW, Balk SP, Taplin ME. PMID: 27683182; PMCID: PMC5315609.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    140. Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy. Clin Genitourin Cancer. 2017 04; 15(2):e289-e298. McKay RR, Jacobus S, Fiorillo M, Ledet EM, Cotogna PM, Steinberger AE, Jacene HA, Sartor O, Taplin ME. PMID: 27651103.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    141. Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2016 12; 19(4):398-405. McKay RR, Werner L, Fiorillo M, Nakabayashi M, Kantoff PW, Taplin ME. PMID: 27502737; PMCID: PMC6034654.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    142. CHALLENGE Trial 1 Year Feasibility Results-Letter. Cancer Epidemiol Biomarkers Prev. 2016 08; 25(8):1277. Pernar CH, Markt SC, McKay RR, Mucci LA. PMID: 27418272; PMCID: PMC4970942.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    143. Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2017 04; 15(2):221-229. Hamieh L, McKay RR, Lin X, Moreira RB, Simantov R, Choueiri TK. PMID: 27460432.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    144. A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies. Cancer. 2016 Aug 01; 122(15):2389-98. McKay RR, De Velasco G, Werner L, Bellmunt J, Harshman L, Sweeney C, Rosenberg JE, Hirsch M, Signoretti S, Van Allen EM, Walsh M, Vaishampayan U, McDermott DF, Choueiri TK. PMID: 27198170; PMCID: PMC5567751.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    145. Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma. J Immunother Cancer. 2016; 4:26. Marmarelis ME, Davis MR, Sethi NS, Krajewksi KM, McKay RR, Choueiri TK, Ott PA. PMID: 27099755; PMCID: PMC4837591.
      View in: PubMed   Mentions:    Fields:    
    146. A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy. J Clin Oncol. 2016 06 01; 34(16):1913-20. McKay RR, Zurita AJ, Werner L, Bruce JY, Carducci MA, Stein MN, Heath EI, Hussain A, Tran HT, Sweeney CJ, Ross RW, Kantoff PW, Slovin SF, Taplin ME. PMID: 27044933; PMCID: PMC5321094.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    147. Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center. Clin Genitourin Cancer. 2016 08; 14(4):e299-305. Muralidhar V, Regan MM, Werner L, Nakabayashi M, Evan CP, Bellmunt J, Choueiri TK, Elfiky AA, Harshman LC, McKay RR, Pomerantz MM, Sweeney CJ, Taplin ME, Kantoff PW, Nguyen PL. PMID: 26778006.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    148. Statins and survival outcomes in patients with metastatic renal cell carcinoma. Eur J Cancer. 2016 Jan; 52:155-62. McKay RR, Lin X, Albiges L, Fay AP, Kaymakcalan MD, Mickey SS, Ghoroghchian PP, Bhatt RS, Kaffenberger SD, Simantov R, Choueiri TK, Heng DY. PMID: 26687834.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    149. Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective. Surg Pathol Clin. 2015 Dec; 8(4):657-62. Albiges L, Fay AP, McKay RR, Kaymakcalan MD, Choueiri TK. PMID: 26612219.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    150. Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Cancer. 2016 Feb 01; 122(3):411-9. Kaymakcalan MD, Xie W, Albiges L, North SA, Kollmannsberger CK, Smoragiewicz M, Kroeger N, Wells JC, Rha SY, Lee JL, McKay RR, Fay AP, De Velasco G, Heng DY, Choueiri TK. PMID: 26540173.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    151. Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Cancer. 2015 Oct 01; 121(19):3435-43. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK. PMID: 26058385.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    152. Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer. Cancer. 2015 Aug 01; 121(15):2603-11. McKay RR, Gray KP, Hayes JH, Bubley GJ, Rosenberg JE, Hussain A, Kantoff PW, Taplin ME. PMID: 25903013; PMCID: PMC4566852.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    153. Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2015 Jun 01; 21(11):2471-9. McKay RR, Rodriguez GE, Lin X, Kaymakcalan MD, Hamnvik OP, Sabbisetti VS, Bhatt RS, Simantov R, Choueiri TK. PMID: 25724518; PMCID: PMC4566854.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    154. Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study. J Immunother Cancer. 2015; 3:3. Fay AP, Signoretti S, Callea M, Tel? GH, McKay RR, Song J, Carvo I, Lampron ME, Kaymakcalan MD, Poli-de-Figueiredo CE, Bellmunt J, Hodi FS, Freeman GJ, Elfiky A, Choueiri TK. PMID: 25767716; PMCID: PMC4357210.
      View in: PubMed   Mentions: 48     Fields:    
    155. Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients. Urology. 2015 Feb; 85(2):343-9. Sammon JD, McKay RR, Kim SP, Sood A, Sukumar S, Hayn MH, Hu JC, Kibel AS, Nguyen PL, Peabody JO, Saad F, Sun M, Varda B, Menon M, Choueiri TK, Trinh QD. PMID: 25623683.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    156. Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma. Eur Urol. 2015 May; 67(5):952-8. Grünwald V, McKay RR, Krajewski KM, Kalanovic D, Lin X, Perkins JJ, Simantov R, Choueiri TK. PMID: 25577718; PMCID: PMC4570832.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    157. The role of miRNAs in prostate cancer. Eur Urol. 2015 Oct; 68(4):589-90. Sun T, McKay R, Lee GS, Kantoff P. PMID: 25577717.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    158. Treatment With Galeterone in an Elderly Man With Castration-Resistant Prostate Cancer: A Case Report. Clin Genitourin Cancer. 2015 Aug; 13(4):e325-e328. McKay RR, Mamlouk K, Montgomery B, Taplin ME. PMID: 25600761; PMCID: PMC4563804.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    159. The burden of skeletal-related events in patients with prostate cancer and bone metastasis. Urol Oncol. 2015 Jan; 33(1):17.e9-17.e18. Roghmann F, Antczak C, McKay RR, Choueiri T, Hu JC, Kibel AS, Kim SP, Kowalczyk KJ, Menon M, Nguyen PL, Saad F, Sammon JD, Schmid M, Sukumar S, Sun M, Noldus J, Trinh QD. PMID: 25443265.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    160. Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway. Cancer. 2015 Jan 15; 121(2):311-9. Hamnvik OP, Choueiri TK, Turchin A, McKay RR, Goyal L, Davis M, Kaymakcalan MD, Williams JS. PMID: 25236375; PMCID: PMC4293233.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    161. Mental health outcomes in elderly men with prostate cancer. Urol Oncol. 2014 Nov; 32(8):1333-40. Ravi P, Karakiewicz PI, Roghmann F, Gandaglia G, Choueiri TK, Menon M, McKay RR, Nguyen PL, Sammon JD, Sukumar S, Varda B, Chang SL, Kibel AS, Sun M, Trinh QD. PMID: 25153773.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    162. Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):325-31. McKay RR, Zukotynski KA, Werner L, Voznesensky O, Wu JS, Smith SE, Jiang Z, Melnick K, Yuan X, Kantoff PW, Montgomery B, Balk SP, Taplin ME. PMID: 25091040; PMCID: PMC4566855.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    163. Adrenocortical carcinoma: the management of metastatic disease. Crit Rev Oncol Hematol. 2014 Nov; 92(2):123-32. Fay AP, Elfiky A, Teló GH, McKay RR, Kaymakcalan M, Nguyen PL, Vaidya A, Ruan DT, Bellmunt J, Choueiri TK. PMID: 24958272; PMCID: PMC4578298.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    164. Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma. Eur Urol. 2014 Sep; 66(3):502-9. McKay RR, Lin X, Perkins JJ, Heng DY, Simantov R, Choueiri TK. PMID: 24613250; PMCID: PMC4145043.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    165. Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC). BJU Int. 2014 May; 113(5b):E67-74. Aizer AA, Urun Y, McKay RR, Kibel AS, Nguyen PL, Choueiri TK. PMID: 24053727; PMCID: PMC4117702.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    166. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls. Transl Oncol. 2014 Feb; 7(1):120-9. Fennessy FM, McKay RR, Beard CJ, Taplin ME, Tempany CM. PMID: 24772215; PMCID: PMC3998683.
      View in: PubMed   Mentions: 8  
    167. Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer. Hematol Oncol Clin North Am. 2013 Dec; 27(6):1261-83, ix. McKay RR, Taplin ME, Choueiri TK. PMID: 24188262; PMCID: PMC4127574.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    168. Rationale for and review of neoadjuvant therapy prior to radical prostatectomy for patients with high-risk prostate cancer. Drugs. 2013 Sep; 73(13):1417-30. McKay RR, Choueiri TK, Taplin ME. PMID: 23943203; PMCID: PMC4127573.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    169. Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. Eur Urol. 2014 Mar; 65(3):577-84. McKay RR, Kroeger N, Xie W, Lee JL, Knox JJ, Bjarnason GA, MacKenzie MJ, Wood L, Srinivas S, Vaishampayan UN, Rha SY, Pal SK, Donskov F, Tantravahi SK, Rini BI, Heng DY, Choueiri TK. PMID: 23962746; PMCID: PMC4123121.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    170. NCCN Task Force Report: Bone Health In Cancer Care. J Natl Compr Canc Netw. 2013 Aug; 11 Suppl 3:S1-50; quiz S51. Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar R, Litsas G, McKay R, Podoloff DA, Srinivas S, Van Poznak CH. PMID: 23997241.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    171. Prostate cancer 2012: where do we stand and where are we heading? Oncology (Williston Park). 2012 Dec; 26(12):1222, 1224. McKay RR, Kantoff P. PMID: 23413607.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature. 2009 Mar 19; 458(7236):322-8. Naish T, Powell R, Levy R, Wilson G, Scherer R, Talarico F, Krissek L, Niessen F, Pompilio M, Wilson T, Carter L, DeConto R, Huybers P, McKay R, Pollard D, Ross J, Winter D, Barrett P, Browne G, Cody R, Cowan E, Crampton J, Dunbar G, Dunbar N, Florindo F, Gebhardt C, Graham I, Hannah M, Hansaraj D, Harwood D, Helling D, Henrys S, Hinnov L, Kuhn G, Kyle P, Läufer A, Maffioli P, Magens D, Mandernack K, McIntosh W, Millan C, Morin R, Ohneiser C, Paulsen T, Persico D, Raine I, Reed J, Riesselman C, Sagnotti L, Schmitt D, Sjunneskog C, Strong P, Taviani M, Vogel S, Wilch T, Williams T. PMID: 19295607.
      View in: PubMed   Mentions: 47     Fields:    Translation:Animals
    173. Standardisation of the measurement of lung volumes. Eur Respir J. 2005 Sep; 26(3):511-22. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. PMID: 16135736.
      View in: PubMed   Mentions: 695     Fields:    Translation:Humans
    174. Measurement of CP-violating asymmetries in B0 decays to CP eigenstates. Phys Rev Lett. 2001 Mar 19; 86(12):2515-22. Aubert B, Boutigny D, De Bonis I, Gaillard JM, Jeremie A, Karyotakis Y, Lees JP, Robbe P, Tisserand V, Palano A, Chen GP, Chen JC, Qi ND, Rong G, Wang P, Zhu YS, Eigen G, Reinertsen PL, Stugu B, Abbott B, Abrams GS, Borgland AW, Breon AB, Brown DN, Button-Shafer J, Cahn RN, Clark AR, Dardin S, Day C, Dow SF, Elioff T, Fan Q, Gaponenko I, Gill MS, Goozen FR, Gowdy SJ, Gritsan A, Groysman Y, Jacobsen RG, Jared RC, Kadel RW, Kadyk J, Karcher A, Kerth LT, Kipnis I, Kluth S, Kolomensky YG, Kral JF, Lafever R, LeClerc C, Levi ME, Lewis SA, Lionberger C, Liu T, Long M, Lynch G, Marino M, Marks K, Meyer AB, Mokhtarani A, Momayezi M, Nyman M, Oddone PJ, Ohnemus J, Oshatz D, Patton S, Perazzo A, Peters C, Pope W, Pripstein M, Quarrie DR, Rasson JE, Roe NA, Romosan A, Ronan MT, Shelkov VG, Stone R, Telnov AV, von der Lippe H, Weber T, Wenzel WA, Zisman MS, Bright-Thomas PG, Harrison TJ, Hawkes CM, Kirk A, Knowles DJ, O'Neale SW, Watson AT, Watson NK, Deppermann T, Koch H, Krug J, Kunze M, Lewandowski B, Peters K, Schmuecker H, Steinke M, Andress JC, Barlow NR, Bhimji W, Chevalier N, Clark PJ, Cottingham WN, De Groot N, Dyce N, Foster B, Mass A, McFall JD, Wallom D, Wilson FF, Abe K, Hearty C, Mattison TS, McKenna JA, Thiessen D, Camanzi B, Jolly S, McKemey AK, Tinslay J, Blinov VE, Bukin AD, Bukin DA, Buzykaev AR, Dubrovin MS, Golubev VB, Ivanchenko VN, Kolachev GM, Korol AA, Kravchenko EA, Onuchin AP, Salnikov AA, Serednyakov SI, Skovpen YI, Telnov VI, Yushkov AN, Lankford AJ, Mandelkern M, McMahon S, Stoker DP, Ahsan A, Buchanan C, Chun S, MacFarlane DB, Prell S, Rahatlou S, Raven G, Sharma V, Burke S, Campagnari C, Dahmes B, Hale D, Hart PA, Kuznetsova N, Kyre S, Levy SL, Long O, Lu A, Richman JD, Verkerke W, Witherell M, Yellin S, Beringer J, Dorfan DE, Eisner AM, Frey A, Grillo AA, Grothe M, Heusch CA, Johnson RP, Kroeger W, Lockman WS, Pulliam T, Sadrozinski H, Schalk T, Schmitz RE, Schumm BA, Seiden A, Spencer EN, Turri M, Walkowiak W, Williams DC, Chen E, Dubois-Felsmann GP, Dvoretskii A, Hanson JE, Hitlin DG, Metzler S, Oyang J, Porter FC, Ryd A, Samuel A, Weaver M, Yang S, Zhu RY, Devmal S, Geld TL, Jayatilleke S, Jayatilleke SM, Mancinelli G, Meadows BT, Sokoloff MD, Bloom P, Fahey S, Ford WT, Gaede F, van Hoek WC, Johnson DR, Michael AK, Nauenberg U, Olivas A, Park H, Rankin P, Roy J, Sen S, Smith JG, Wagner DL, Blouw J, Harton JL, Krishnamurthy M, Soffer A, Toki WH, Warner DW, Wilson RJ, Zhang J, Brandt T, Brose J, Colberg T, Dahlinger G, Dickopp M, Dubitzky RS, Eckstein P, Futterschneider H, Krause R, Maly E, Müller-Pfefferkorn R, Otto S, Schubert KR, Schwierz R, Spaan B, Wilden L, Behr L, Bernard D, Bonneaud GR, Brochard F, Cohen-Tanugi J, Ferrag S, Fouque G, Gastaldi F, Matricon P, Mora de Freitas P, Renard C, Roussot E, T'Jampens S, Thiebaux C, Vasileiadis G, Verderi M, Anjomshoaa A, Bernet R, Di Lodovico F, Khan A, Muheim F, Playfer S, Swain JE, Falbo M, Bozzi C, Dittongo S, Folegani M, Piemontese L, Treadwell E, Anulli F, Baldini-Ferroli R, Calcaterra A, de Sangro R, Falciai D, Finocchiaro G, Patteri P, Peruzzi IM, Piccolo M, Xie Y, Zallo A, Bagnasco S, Buzzo A, Contri R, Crosetti G, Lo Vetere M, Macri M, Monge MR, Pallavicini M, Passaggio S, Pastore FC, Patrignani C, Pia MG, Robutti E, Santroni A, Morii M, Bartoldus R, Dignan T, Hamilton R, Mallik U, Cochran J, Crawley HB, Fischer PA, Lamsa J, McKay R, Meyer WT, Rosenberg EI, Albert JN, Beigbeder C, Benkebil M, Breton D, Cizeron R, Du S, Grosdidier G, Hast C, Höcker A, LePeltier V, Lutz AM, Plaszczynski S, Schune MH, Trincaz-Duvoid S, Truong K, Valassi A, Wormser G, Bionta RM, Brigljevic V, Brooks A, Fackler O, Fujino D, Lange DJ, Mugge M, O'Connor TG, Pedrotti B, Shi X, van Bibber K, Wenaus TJ, Wright DM, Wuest CR, Yamamoto B, Carroll M, Fry JR, Gabathuler E, Gamet R, George M, Kay M, Payne DJ, Sloane RJ, Touramanis C, Aspinwall ML, Bowerman DA, Dauncey PD, Egede U, Eschrich I, Gunawardane NJ, Martin R, Nash JA, Price DR, Sanders P, Smith D, et al. PMID: 11289970.
      View in: PubMed   Mentions:    Fields:    
    175. Diabetes in Victoria, Australia: the Visual Impairment Project. Aust N Z J Public Health. 2000 Dec; 24(6):565-9. McKay R, McCarty CA, Taylor HR. PMID: 11215002.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    176. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci. 2000 Oct 01; 20(19):7377-83. Studer L, Csete M, Lee SH, Kabbani N, Walikonis J, Wold B, McKay R. PMID: 11007896; PMCID: PMC6772777.
      View in: PubMed   Mentions: 231     Fields:    Translation:AnimalsCells
    177. Multiple subtypes of phospholipase C are encoded by the norpA gene of Drosophila melanogaster. J Biol Chem. 1995 Jun 16; 270(24):14376-82. Kim S, McKay RR, Miller K, Shortridge RD. PMID: 7540168.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    178. Phospholipase C rescues visual defect in norpA mutant of Drosophila melanogaster. J Biol Chem. 1995 Jun 02; 270(22):13271-6. McKay RR, Chen DM, Miller K, Kim S, Stark WS, Shortridge RD. PMID: 7768926.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    179. Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol. 1991 Jul; 18(1):159-65. Sreeram N, Saleem M, Jackson M, Peart I, McKay R, Arnold R, Walsh K. PMID: 1711062.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    180. Operative findings after percutaneous pulmonary balloon dilatation of the right ventricular outflow tract in tetralogy of Fallot. Br Heart J. 1990 Nov; 64(5):321-4. Battistessa SA, Robles A, Jackson M, Miyamoto S, Arnold R, McKay R. PMID: 2245111; PMCID: PMC1216811.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    181. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature. 1990 Oct 25; 347(6295):762-5. Cattaneo E, McKay R. PMID: 2172829.
      View in: PubMed   Mentions: 140     Fields:    Translation:AnimalsCells
    182. Intramitochondrial localization of delta-aminolaevulate synthetase and ferrochelatase in rat liver. Biochem J. 1969 Sep; 114(3):455-61. McKay R, Druyan R, Getz GS, Rabinowitz M. PMID: 5820634; PMCID: PMC1184917.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    Rana's Networks
    Concepts (470)
    Derived automatically from this person's publications.
    _
    Co-Authors (72)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _